Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is not known to cause psychiatric side effects as a direct pharmacological action, but some people do notice changes in mood, motivation or emotional wellbeing during treatment. These experiences are real and worth understanding — and they are separate from the gastrointestinal effects that most people associate with tirzepatide's common side effects. As a prescription-only medicine, Mounjaro requires a clinical assessment before it can be prescribed; a GPhC-registered prescriber reviews your full health picture, including your mental health history, as part of that process.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Looking at the Mounjaro Summary of Product Characteristics (SmPC), psychiatric conditions are not among the side effects identified with a recognised frequency. The primary adverse reactions documented are gastrointestinal: nausea, vomiting, diarrhoea and constipation feature prominently, particularly in the weeks after starting treatment or after a dose increase. The NHS tirzepatide medicines page reflects this profile.
That said, regulatory agencies including the MHRA have kept GLP-1 receptor agonists and related medicines under active review for psychiatric signals following earlier concerns raised with other weight-loss medicines. The MHRA's Black Triangle status for Mounjaro means any new safety data (including reports of mood changes) is actively collected and assessed. This is not a red flag; it is the system working as it should for newer medicines.
The honest answer is that a clear causal link between tirzepatide specifically and depression or anxiety has not been established in the clinical trial data to date, and anyone wanting a fuller picture of the mental side effects associated with Mounjaro will find a detailed breakdown on that page. But absence of proof is not the same as proof of absence, and anyone noticing meaningful changes in their mental health during treatment deserves a proper conversation with their prescriber, not a dismissive reassurance.
This is the question our prescribers hear most often, and it is a genuinely important one. Significant changes in appetite, eating patterns and body weight can carry emotional weight that has nothing to do with the medicine's direct pharmacology.
Some people find that the reduction in food cravings (one of tirzepatide's most noticeable effects) is disorienting at first. Food plays a social and emotional role for most of us, and when that relationship shifts quickly, feelings of low mood, flatness or even mild grief are not unusual. That is not Mounjaro doing something wrong; it is a human response to a significant change in daily life. The broader health considerations around Mounjaro cover this kind of context in more depth.
Rapid weight loss can also bring complex emotions: relief, but sometimes anxiety about maintaining progress, or a sense of identity shift as your body changes. These responses are worth acknowledging. A dietitian or counsellor alongside your prescriber can be a useful part of the picture. If you have a history of disordered eating, make sure your prescriber knows before you start treatment, it is directly relevant to assessing whether Mounjaro is suitable for you. If you need support, Beat offers confidential help with eating disorders and body-image concerns.
Certain symptoms need prompt attention, not a wait-and-see approach. Contact your GP, call 111, or seek urgent medical help if you experience thoughts of self-harm or suicide at any point during Mounjaro treatment. These warrant immediate support regardless of whether you believe them to be medicine-related.
You should also speak to your prescriber (without delay, though not on an emergency basis) if you notice:
At nume, our prescribers are available for aftercare seven days a week. Any mood-related concerns raised after starting treatment are reviewed clinically, not filtered out. You can also report any suspected side effect, including psychological ones, to the MHRA via the Yellow Card scheme, patient reports genuinely contribute to the body of evidence that shapes future guidance.
For men specifically, mood changes can sometimes present differently and be harder to name, our page on Mounjaro side effects in men looks at some of those patterns.
Because Mounjaro is a prescription-only medicine, the consultation before any prescription is issued covers more than your BMI. A GPhC-registered Independent Prescriber reads your answers, your medical history, current medicines, and any mental health conditions or history. That review happens the same day you submit your consultation, and it is done by a real clinician, not an automated system.
Mental health history is relevant to prescribing decisions in two ways: some conditions or medicines may interact with treatment, and a prescriber needs to understand the baseline so that any changes during treatment can be interpreted meaningfully. If you are currently taking antidepressants, mood stabilisers or antipsychotics, mention them, this also matters for any potential absorption changes, particularly in the early weeks of treatment. Our clinical team takes this kind of whole-person assessment seriously.
The side effects of Mounjaro's less-discussed physical effects and how to manage nausea are also covered as part of aftercare. If you keep your Mounjaro pen in the fridge door next to everyday items, it is a small but useful reminder to check in with yourself each week, not just on the physical, but on how you are feeling overall. If something has shifted, that weekly moment is a good prompt to reach out.
If you would like to discuss your mental health history as part of a clinical consultation, our prescribers cover exactly this. Check your eligibility and start your free consultation today.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.